Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 05/31/2024 | 96,493,078 | Total gross of voting rights: 96,493,078 |
| Total net* of voting rights: 96,236,383 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$3.14 |
| Daily Change: | -0.16 -4.70 |
| Daily Volume: | 36,307 |
| Market Cap: | US$64.430M |
December 11, 2024 November 06, 2024 October 22, 2024 September 23, 2024 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
